Effects of co-administered ezetimibe and fenofibrate in mixed dyslipidaemic patients with metabolic syndrome

被引：0
|
作者：
Davies, M. J.
Bays, H. E.
Shah, A.
Macdonell, G.
Gumbiner, B.
机构：
[1] Merck & Co Inc, Rahway, NJ 07065 USA
[2] LMARC, Clin Res, Louisville, KY USA
来源：
DIABETOLOGIA | 2006年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0746
引用
收藏
页码：452 / 453
页数：2
相关论文
共 50 条
  • [31] Efficacity and tolerance in the long-term of the co-administration of fenofibrate and ezetimibe in patients with mixed hyperlipidemy
    Farnier, M
    Mc Kenney, J
    Lo, KW
    Perevozskhaya, I
    Carlson, G
    Macdonell, G
    Davies, M
    Mitchel, Y
    Gumbiner, B
    DIABETES & METABOLISM, 2006, 32 : S37 - S38
  • [32] Is combined treatment with fenofibrate and ezetimibe safe and efficacious in patients with mixed hyperlipidemia?
    Michael H Davidson
    Nature Clinical Practice Cardiovascular Medicine, 2006, 3 : 594 - 595
  • [33] Efficacy and safety of the coadministration of ezetimibe/simvastatin with fenofibrate in patients with mixed hyperlipidemia
    Farnier, Michel
    Roth, Eli
    Gil-Extremera, Blas
    Mendez, Gustavo F.
    Macdonell, Geraldine
    Hamlin, Constance
    Perevozskaya, Inna
    Davies, Michael J.
    Kush, Debra
    Mitchel, Yale B.
    AMERICAN HEART JOURNAL, 2007, 153 (02) : 335.e1 - 335.e8
  • [34] Is combined treatment with fenofibrate and ezetimibe safe and efficacious in patients with mixed hyperlipidemia?
    Davidson, Michael H.
    NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE, 2006, 3 (11): : 594 - 595
  • [35] Lack of clinically relevant drug-drug interactions when dalcetrapib is co-administered with ezetimibe
    Derks, Michael
    Abt, Markus
    Phelan, Mary
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 70 (06) : 825 - 833
  • [36] Consistency of LDL-C lowering effect across subgroups of ezetimibe co-administered with statins
    Lipka, L
    Melani, L
    LeBeaut, A
    Sun, S
    Suresh, R
    Veltri, E
    EUROPEAN HEART JOURNAL, 2002, 23 : 19 - 19
  • [37] Effects of the co-administration of ezetimibe/simvastatine and fenofibrate on the lipoproteins sub-classes and on the LDL size profile in patients with mixed hyperlipidemia
    Farnier, M.
    Perevozskaya, I.
    Taggart, W.
    Kush, D.
    Mitchel, Y.
    DIABETES & METABOLISM, 2007, 33 : S59 - S60
  • [38] Effect of coadministered ezetimibe and fenofibrate on the atherogenic dyslipidemia in obese patients with mixed hyperlipidemia
    Davies, M
    Shah, A
    Macdonell, G
    Gumbiner, B
    OBESITY RESEARCH, 2005, 13 : A132 - A133
  • [39] Ezetimibe co-administered with ongoing atorvastatin therapy in achieving low-density lipoprotein goal in patients with coronary heart disease
    Fernández, JMC
    Bedarida, GV
    Adgey, J
    Allen, C
    Johnson-Levonas, AO
    Massaad, R
    ATHEROSCLEROSIS SUPPLEMENTS, 2005, 6 (01) : 104 - 104
  • [40] Effect of co-administration of ezetimibe/sinivastatin and fenofibrate on apolipoproteins (A-I, B, and CIII) in patients with mixed hyperlipidemia
    Famier, M.
    Roth, E. M.
    Perevozskaya, I. T.
    Davies, M. J.
    Kush, D.
    Mitche, Y. B.
    ATHEROSCLEROSIS SUPPLEMENTS, 2007, 8 (01) : 206 - 207
12345